v3.26.1
STOCKHOLDERS’ DEFICIT
12 Months Ended
Mar. 31, 2026
Equity [Abstract]  
STOCKHOLDERS’ DEFICIT

NOTE – 8 STOCKHOLDERS’ DEFICIT

 

The Company is authorized to issue two classes of capital stock, up to 36,100,000,000 shares.

 

Preferred Stock

 

The Company is authorized to issue 100,000,000 shares of preferred stock, with a par value of $0.0001. The Company has one class of Preferred Stock designated with 50,000,000 shares authorized as Series C Preferred Stock, with a par value of $0.001 per share. Each one share of Series C Convertible Preferred Stock converts into 100 shares of common stock of the Company at the election of the holder, subject to equitable adjustments.

 

As of March 31, 2026 and 2025, the Company had 30,000,000 shares of Series C Preferred Stock issued and outstanding.

 

Common Stock

 

The Company is authorized to issue 36,000,000,000 shares of common stock, with a par value of $0.0001.

 

On July 15, 2025 and October 8, 2025, the Company issued 1,400,000 and 74,940,616 shares of its common stock for settlement of inventory purchases.

 

On July 15, 2025, December 16, 2025 and December 26, 2025, the Company issued 1,333,333, 8,000,000 and 2,000,000 shares of its common stock to settle the consulting and service fee to consultants who provided the services to the Company, respectively.

 

On September 9, 2025, the Company effectuated a reverse split of its common shares at a ratio of 1-for-10,000. All share and per share amounts have been retroactively adjusted to reflect the reverse split for all years presented. Such number of additional shares of common stock so that each Affected Shareholder shall hold 100 shares of common stock of the Company after the Reverse Stock Split, with additional 882,737 fractional shares.

 

On December 26, 2025, the Company approved the rescission and cancellation each of 1,000,000 shares of common stock previously issued to Lam Ka Ho Gary and Lau Tin Yam on December 16, 2025, respectively.

 

On December 30, 2025, the company cancelled 76,340,616 shares of its common stock due to the termination of thirty-five sales agreements previously entered on April 7, 2025. The cancellation was completed on March 27, 2026. 

 

As of March 31, 2026 and 2025, the Company had a total of 10,881,149 and 665,079 shares of its common stock issued and outstanding, respectively.

 

Deferred compensation

 

On July 15, 2025 and December 16, 2025, the Company issued 1,333,333 and 8,000,000 shares of its common stock to settle the consulting and service fee to consultants who provided the marketing campaign and develop new business services to the Company, respectively.

 

At March 31, 2026 and 2025, the Company’s share issued for services rendered was $4,878,400 and $0, respectively, which is recorded in deferred compensation in the accompanying consolidated balance sheets.

 

The Company recognized the amortization of deferred compensation $2,409,000 and $0 for the years ended March 31, 2026 and 2025.